United Nations Department of Economic and Social Affairs Population Division. World population ageing 2013. http://www.un.org/en/development/desa/population/publications/pdf. Accessed 15 Jan 2023

Dharmarajan K, Strait KM, Tinetti ME et al (2016) Treatment for multiple acute cardiopulmonary conditions in older adults hospitalized with pneumonia, chronic obstructive pulmonary disease, or heart failure. J Am Geriatr Soc 64:1574–1582

Article  PubMed  PubMed Central  Google Scholar 

Fuller GF (2000) Falls in the elderly. Am Fam Physician 61:2159–2168

CAS  PubMed  Google Scholar 

Mair A, Wilson M, Dreischulte T (2020) Addressing the challenge of polypharmacy. Annu Rev Pharmacol Toxicol 60:661–681

Article  CAS  PubMed  Google Scholar 

Judge A, Javaid MK, Leal J et al (2016) Models of care for the delivery of secondary fracture prevention after hip fracture: a health service cost, clinical outcomes and cost-effectiveness study within a region of England. Health Serv Deliv Res. https://doi.org/10.3310/hsdr04280

Article  Google Scholar 

Castelli A, Daidone S, Jacobs R, Kasteridis P, Street AD (2015) The determinants of costs and length of stay for hip fracture patients. PLoS ONE 10:e0133545

Article  PubMed  PubMed Central  Google Scholar 

Royal College of Physicians. NHFD annual report 2019. https://www.rcplondon.ac.uk/projects/outputs/nhfd-annual-report-2019

Spinewine A, Schmader KE, Barber N et al (2007) Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 370:173–184

Article  PubMed  Google Scholar 

Wise J (2013) Polypharmacy: a necessary evil. BMJ 347:f7033

Article  PubMed  Google Scholar 

Cahir C, Fahey T, Teeling M, Teljeur C, Feely J, Bennett K (2010) Potentially inappropriate prescribing and cost outcomes for older people: a national population study. Br J Clin Pharmacol 69:543–552

Article  PubMed  PubMed Central  Google Scholar 

Lu WH, Wen YW, Chen LK, Hsiao FY (2015) Effect of polypharmacy, potentially inappropriate medications and anticholinergic burden on clinical outcomes: a retrospective cohort study. CMAJ 187:E130–E137

Article  PubMed  PubMed Central  Google Scholar 

Salahudeen MS, Hilmer SN, Nishtala PS (2015) Comparison of anticholinergic risk scales and associations with adverse health outcomes in older people. J Am Geriatr Soc 63:85–90

Article  PubMed  Google Scholar 

Liang CK, Chou MY, Hsu YH et al (2023) The association of potentially inappropriate medications, polypharmacy and anticholinergic burden with readmission and emergency room revisit after discharge: a hospital-based retrospective cohort study. Br J Clin Pharmacol 89:187–200

Article  CAS  PubMed  Google Scholar 

De Vincentis A, Gallo P, Finamore P et al (2020) Potentially inappropriate medications, drug–drug interactions, and anticholinergic burden in elderly hospitalized patients: does an association exist with post-discharge health outcomes? Drugs Aging 37:585–593

Article  PubMed  Google Scholar 

Hanlon P, Quinn TJ, Gallacher KI et al (2020) Assessing risks of polypharmacy involving medications with anticholinergic properties. Ann Fam Med 18:148–155

Article  PubMed  PubMed Central  Google Scholar 

National Audit Office (2016) Discharging older patients from hospital. Report by the Comptroller and Auditor General. NAO, London. http://www.nao.org.uk/wp-content/uploads/2015/12/Discharging-older-patients-from-hospital-Summary.pdf. Accessed 15 Jan 2023

Kaye KS, Marchaim D, Chen TY et al (2014) Effect of nosocomial bloodstream infections on mortality, length of stay, and hospital costs in older adults. J Am Geriatr Soc 62:306–311

Article  PubMed  PubMed Central  Google Scholar 

Han TS, Murray P, Robin J, Wilkinson P, Fluck D, Fry CH (2022) Evaluation of the association of length of stay in hospital and outcomes. Int J Qual Health Care 34:mzab160

PubMed  Google Scholar 

Lisk R, Uddin M, Parbhoo A et al (2019) Predictive model of length of stay in hospital among older patients. Aging Clin Exp Res 31:993–999

Article  PubMed  Google Scholar 

World Health Organization (2004) ICD-10: international statistical classification of diseases and related health problems: tenth revision. WHO, Geneva

Google Scholar 

Yeong K, Lisk R, Watters H et al (2023) Pre-fracture mobility using standardized scale as an early indicator of high health risk in patients with a hip fracture. Ageing Int 48:301–315

Article  Google Scholar 

Aging Brain Care. Anticholinergic cognitive burden scale. Regenstrief Institute, 2012. https://corumpharmacy.com/wp-content/uploads/2020/08/Anticholinergic-cognitive-burden-scale.pdf. Accessed 15 Jan 2023

Nakham A, Myint PK, Bond CM et al (2020) Interventions to reduce anticholinergic burden in adults aged 65 and older: a systematic review. J Am Med Dir Assoc 21:172–180

Article  PubMed  Google Scholar 

van der Meer HG, Wouters H, Pont LG, Taxis K (2018) Reducing the anticholinergic and sedative load in older patients on polypharmacy by pharmacist-led medication review: a randomised controlled trial. BMJ Open 8:e019042

Article  PubMed  PubMed Central  Google Scholar 

Davies EA, O’mahony MS (2015) Adverse drug reactions in special populations–the elderly. Br J Clin Pharmacol 80:796–807

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lavan AH, Gallagher P (2016) Predicting risk of adverse drug reactions in older adults. Ther Adv Drug Saf 7:11–22

Article  PubMed  PubMed Central  Google Scholar 

Fox KM, Cummings SR, Williams E, Stone K, Study of Osteoporotic Fractures (2000) Femoral neck and intertrochanteric fractures have different risk factors: a prospective study. Osteoporos Int 11:1018–1023

Article  CAS  PubMed  Google Scholar